|
Baseline characteristic
|
Bupropion plus aripiprazole (n = 46)
|
SSRI/SNRI plus aripiprazole (n = 242)
|
|---|
|
Age (years), mean (SD)
|
45.0 (12.9)
|
46.6 (12.6)
|
|
Gender, n (%)
| | |
|
Females
|
30 (65.2)
|
166 (68.6)
|
|
Race, n (%)
| | |
|
White
|
40 (87.0)
|
223 (92.1)
|
|
Black
|
4 (8.7)
|
12 (5.0)
|
|
Asian
|
0
|
2 (0.8)
|
|
Other
|
2 (4.3)
|
5 (2.1)
|
|
Weight (kg), mean (SD)
|
93.4 (23.2)
|
87.7 (22.4)
|
|
BMI (kg/m2), mean (SD)
|
32.5 (8.6)
|
31.2 (8.1)
|
|
CGI-S score, mean (SD)
|
4.2 (0.6)
|
4.2 (0.6)
|
|
MADRS Total score, mean (SD)
|
24.5 (4.8)
|
25.1 (6.0)
|
|
IDS-Self Rated Total score, mean (SD)
|
34.6 (9.4)
|
38.2 (10.5)
|
|
QIDS-Self Rated Total score, mean (SD)
|
13.5 (3.9)
|
14.6 (4.2)
|
- CGI-S, Clinical Global Impressions–Severity score; IDS, Inventory of Depressive Symptomatology; MADRS, Montgomery–Åsberg Depression Rating Scale; QIDS, Quick Inventory of Depressive Symptomatology; SD, standard deviation; SNRI, serotonin–norepinephrine reuptake inhibitor; SSRI, selective serotonin reuptake inhibitor.
